Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
Canopy Growth Corporation is a drug manufacturers—specialty & generic business based in the US. Canopy Growth Corporation shares (CGC) are listed on the NYSE and all prices are listed in US Dollars. Canopy Growth Corporation employs 4,434 staff and has a market cap (total outstanding shares value) of USD$6.4 billion.
Since the stock market crash in March caused by coronavirus, Canopy Growth Corporation's share price has had significant negative movement.
Its last market close was USD$19.81, which is 9.46% down on its pre-crash value of USD$21.88 and 120.11% up on the lowest point reached during the March crash when the shares fell as low as USD$9.
If you had bought USD$1,000 worth of Canopy Growth Corporation shares at the start of February 2020, those shares would have been worth USD$565.38 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$896.01.
|Latest market close||USD$19.81|
|52-week range||USD$9 - USD$25.97|
|50-day moving average||USD$15.9391|
|200-day moving average||USD$16.4112|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-1.794|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-10-13)||5.94%|
|1 month (2020-09-18)||21.09%|
|3 months (2020-07-20)||11.98%|
|6 months (2020-04-20)||30.59%|
|1 year (2019-10-18)||-1.98%|
|2 years (2018-10-19)||-57.72%|
|3 years (2017-10-20)||95.58%|
|5 years (2015-10-20)||1,176.42%|
|Gross profit TTM||USD$105.1 million|
|Return on assets TTM||-6.72%|
|Return on equity TTM||-23.7%|
|Market capitalisation||USD$6.4 billion|
TTM: trailing 12 months
There are currently 47.0 million Canopy Growth Corporation shares held short by investors – that's known as Canopy Growth Corporation's "short interest". This figure is 0.8% up from 46.6 million last month.
There are a few different ways that this level of interest in shorting Canopy Growth Corporation shares can be evaluated.
Canopy Growth Corporation's "short interest ratio" (SIR) is the quantity of Canopy Growth Corporation shares currently shorted divided by the average quantity of Canopy Growth Corporation shares traded daily (recently around 3.5 million). Canopy Growth Corporation's SIR currently stands at 13.37. In other words for every 100,000 Canopy Growth Corporation shares traded daily on the market, roughly 13370 shares are currently held short.
However Canopy Growth Corporation's short interest can also be evaluated against the total number of Canopy Growth Corporation shares, or, against the total number of tradable Canopy Growth Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Canopy Growth Corporation's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 Canopy Growth Corporation shares in existence, roughly 130 shares are currently held short) or 0.5318% of the tradable shares (for every 100,000 tradable Canopy Growth Corporation shares, roughly 532 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Canopy Growth Corporation.
Find out more about how you can short Canopy Growth Corporation stock.
We're not expecting Canopy Growth Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Canopy Growth Corporation's shares have ranged in value from as little as $9 up to $25.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Canopy Growth Corporation's is 2.3147. This would suggest that Canopy Growth Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.